| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 07/22/2003 | USRE38200 Indole-2,3-dione-3-oxime derivatives |
| 07/22/2003 | US6596869 Reacting cyanoquinuclidine compound with isoamyl nitrite for nitrosation |
| 07/22/2003 | US6596726 Method of inhibiting epidermal growth factor by treating, with an effective inhibiting amount, a mammal, in need thereof inhibit the epidermal growth factor receptor and related receptors and, in particular, their tyrosine kinase enzyme |
| 07/17/2003 | WO2003057699A1 Dibenzodiazepine derivates, their preparation and use |
| 07/17/2003 | WO2003057667A2 Strapped and modified bis (benzimidazole) diamides for asymmetric catalysts and other applications |
| 07/17/2003 | WO2003057213A2 Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptor |
| 07/17/2003 | WO2003057207A1 Methods for treating hearing loss |
| 07/17/2003 | WO2003057149A2 4-substituted fused heteropyrimidines and fused hetero-4-pyrimidones |
| 07/17/2003 | WO2003056899A2 Nitric oxide donors for treatment of disease and injury |
| 07/17/2003 | WO2003008410A3 Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression |
| 07/17/2003 | US20030135049 Preparing camptothecin intermediates |
| 07/17/2003 | US20030135045 Glycoprotein IIb/IIIa antagonists |
| 07/17/2003 | US20030135044 Novel gamma secretase inhibitors |
| 07/17/2003 | US20030135043 Novel synthesis and crystallization of piperazine ring-containing compounds |
| 07/17/2003 | US20030134867 Preventing extracellular release |
| 07/17/2003 | US20030134863 Preventives/remedies for alzheimer's disease |
| 07/17/2003 | US20030134862 Compounds |
| 07/17/2003 | US20030134847 New polycyclic azaindole compounds |
| 07/17/2003 | US20030134845 Biologically active vasopressin agonist metabolites |
| 07/17/2003 | US20030134840 Novel compounds |
| 07/17/2003 | US20030134827 Lactams or pharmaceutically acceptable salt forms thereof, wherein rings ring B is a 4-8 membered cyclic amide containing from 0-3 additional heteroatoms selected from N, O, and S, which are useful as metalloprotease inhibitors. |
| 07/17/2003 | CA2825792A1 Otoprotectant compositions of glutathione peroxidase mimics for ameliorating hearing loss |
| 07/17/2003 | CA2472678A1 Otoprotectant compositions of glutathione peroxidase mimics for ameliorating hearing loss |
| 07/16/2003 | EP1327636A2 Heterocyclic metallocenes and polymerisation catalysts |
| 07/16/2003 | EP1327633A1 Crystallization of 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo(5.5.0.0.59O3,11)-dodecane |
| 07/16/2003 | EP1327632A1 Method for producing trimer of indole derivative, and trimer of indole derivative and laminated structure thereof |
| 07/16/2003 | EP1327631A2 Fused heterocyclic compounds, their production and use as angiotensin II antagonists |
| 07/16/2003 | EP1326875A2 Tumor proliferation inhibitors |
| 07/16/2003 | EP1326867A2 Bridged piperazine derivatives |
| 07/16/2003 | EP1326866A1 Substituted 3.4-dihydro-pyrido[1,2-a]pyrimidines |
| 07/16/2003 | EP1326865A2 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| 07/16/2003 | EP1326863A2 Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines |
| 07/16/2003 | EP1326830A1 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy |
| 07/16/2003 | EP1326619A2 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 07/16/2003 | EP1326615A1 Phosphoric acid salt of an integrin receptor antagonist |
| 07/16/2003 | EP1326613A1 Use of substituted imidazo 1,2-a]pyridine-, imidazo 1,2-a]pyrimidine and imidazo 1,2-a]pyrazine-3-yl-amine derivatives for producing nos-inhibiting medicaments |
| 07/16/2003 | EP1326603A1 Composition comprising a catalyst for the dismutation of superoxide and use of the composition for preventing and treating hypotension |
| 07/16/2003 | EP0787720B1 Pyridonecarboxylate derivative or salt thereof and antibacterial containing the same as active ingredient |
| 07/16/2003 | CN1430611A 1,4-diazepan-2,5-dione derivatives and their use as NK-1 receptor antagonists |
| 07/16/2003 | CN1430610A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 07/16/2003 | CN1430607A Benzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 07/16/2003 | CN1114608C Novel camptothecine analogues, prepn. method therefor, use thereof, and pharmaceutical compositions contg. same |
| 07/16/2003 | CN1114607C Carbostyril carboxylic acid derivatives |
| 07/16/2003 | CN1114606C Fungicidal 7-alkyl-triazolopyrimidines compound |
| 07/16/2003 | CN1114403C Vitronectin receptor antagonists |
| 07/15/2003 | US6593344 These substances have especially high cytostatic activities and pronounced immunosuppressive properties which make them suitable for therapeutic treatment in broad tumor spectrum and autoimmune diseases |
| 07/10/2003 | WO2003055888A1 Hydroxycucurbituril derivatives, their preparation methods and uses |
| 07/10/2003 | WO2003055887A1 Conjugated porphyrin, chlorin or bacteriochlorin chromophore |
| 07/10/2003 | WO2003055886A1 Amorphous substance of tricyclic triazolobenzazepine derivative |
| 07/10/2003 | WO2003055885A1 Novel crystalline tricyclic triazolobenzazepine derivative |
| 07/10/2003 | WO2003055884A1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use |
| 07/10/2003 | WO2003055883A1 Pyrimidotriazines as phosphatase inhibitors |
| 07/10/2003 | WO2003055882A1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 07/10/2003 | WO2003055856A2 BICYCLIC LACTAM DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE) |
| 07/10/2003 | WO2003055447A2 Heterocyclic acridone inhibitors of impdh enzyme |
| 07/10/2003 | WO2003041653A3 Cytotoxic agents |
| 07/10/2003 | WO2002100354A8 Pyrrolo[2,3-d]pyrimidine nucleoside analogs |
| 07/10/2003 | US20030130509 Process to produce 3-carbon amino alcohol salts |
| 07/10/2003 | US20030130503 Crystallization of 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.05,903,11]-dodecane |
| 07/10/2003 | US20030130305 Azabicyclic-phenyl-fused-heterocyclic compounds for treatment of disease |
| 07/10/2003 | US20030130292 Immunosuppressants; autoimmune disease; skin disorders; Crohn's disease; antidiabetic agents; anticancer agents; antiarthritic agents |
| 07/10/2003 | US20030130291 Dissolving in solvents; precipitation; isolation; sleep disorders |
| 07/10/2003 | US20030130284 Animal growth regulators; osteoporosis; congestive heart failure; muscular disorders |
| 07/10/2003 | US20030130283 CRF receptor antagonists and methods relating thereto |
| 07/10/2003 | US20030130273 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE) |
| 07/10/2003 | US20030130271 1,3-Diheterocyclic metalloprotease inhibitors |
| 07/10/2003 | US20030130269 Derivatives of octahydro-6, 10-dioxo-6H-pyridazino [1,2-a] [1,2] diazepine-1-carboxylic acid, their preparation process and their use in the preparation of therapeutically active compounds |
| 07/10/2003 | US20030130252 Process for affecting neurologic progression |
| 07/10/2003 | US20030130168 Reverse-turn mimetics and methods relating thereto |
| 07/09/2003 | EP1325011A2 Methods and compounds for treating proliferative diseases |
| 07/09/2003 | EP1325010A1 Substituted 3.4-dihydro-pyrimido 1,2-a]pyrimidines and 3.4-dihydropyrazino 1,2-a]pyrimidines |
| 07/09/2003 | EP1325009A2 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same |
| 07/09/2003 | EP1325008A1 Piperazine derivatives |
| 07/09/2003 | EP1325007A2 Hexahydropyrazino[1'2':1,6]-pyrido[3,4-b]indole-1,4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction |
| 07/09/2003 | EP1325006A2 Heterocyclic compounds as ligands of the gaba a? receptor |
| 07/09/2003 | EP1325005A1 1,2,5,10-tetrahydropyridazino 4,5-b]quinoline-1,10-diones and their use for the treatment of pain |
| 07/09/2003 | EP0888353B1 N-7-HETEROCYCLYL PYRROLO [2,3-d]PYRIMIDINES AND THEIR USE |
| 07/09/2003 | EP0823906B1 Piperazino derivatives as neurokinin antagonists |
| 07/09/2003 | EP0759921B1 Process for the preparation of azabicyclic derivatives |
| 07/09/2003 | CN1429229A Hydroxylamine esters as polymerization initiators |
| 07/09/2003 | CN1428342A Method for preparing pheophorbide A and pheophytic C by using marine alga |
| 07/09/2003 | CN1113895C Growth hormone secretagogues |
| 07/09/2003 | CN1113890C Heterocyclic metallocenes and polymerization catalysts |
| 07/09/2003 | CN1113882C Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents |
| 07/09/2003 | CN1113875C Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 07/09/2003 | CN1113696C Process for producing phosphate catalyst for producing triethylene diamine |
| 07/08/2003 | US6589957 Compounds and methods of use for treatment of neurogenic inflammation |
| 07/08/2003 | US6589952 Imidazo[1,2-a]pyrazines for the treatment of neurological disorders |
| 07/08/2003 | US6589325 Phthalocyanine compounds, water-base ink compositions and colored products |
| 07/03/2003 | WO2003053976A1 PIPAZOLO [1,5-a] PYRIMIDINE DERIVATIVES AS MODULATORS OF PPAR |
| 07/03/2003 | WO2003053975A1 Pyrazolopyrimidinone derivatives having pde7-inhibitory activity |
| 07/03/2003 | WO2003053974A1 Novel compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| 07/03/2003 | WO2003053973A1 Pyrazolyl-substituted triazoloquinoxalines |
| 07/03/2003 | WO2003053969A1 Imidazoquinoline derivatives |
| 07/03/2003 | WO2003053957A1 Benzhydryl derivatives |
| 07/03/2003 | WO2003053941A2 Barbituric acid derivatives as inhibitors of tnf-alpha converting enzyme (tace) and/or matrix metalloproteinases |
| 07/03/2003 | WO2003053561A2 A surfactant assisted nanomaterial generation process |
| 07/03/2003 | WO2003053445A1 Use of desoxypeganine for treating clinical depression |
| 07/03/2003 | WO2003053444A1 New use |
| 07/03/2003 | WO2003053366A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use |